glp 1 blood clots Do GLP-1 Drugs Cause Clots? Evidence and Guidance January 2025: GLP Drugs -

DPP-4 inhibitors were not included in the two tiers because their effectiveness on glycemic control is lower than or equivalent to first- and second-tier agents, as well as for less clinical evidence and relative expense

The dual GLP-1/GIP agonist tirzepatide demonstrates potent efficacy, which indicates better potential for cardiovascular risk reduction

In the Super Bowl ad, the disclaimer that its compounded medications aren't FDA-approved was displayed briefly and in a very small font

18 For type 1 diabetes, the Diabetes Complications and Control Trial showed that complications--including retinopathy, nephropathy and neuropathy--can be delayed or prevented with intensive insulin therapy